There is no evidence of a direct link
between the AstraZeneca vaccine and blood clots, European
Medicines Agency (EMA) executive director Emer Cooke said
Tuesday.
However, EMA is conducting a "rigorous" analysis of the reported
clots, assessing them on a case-by-case basis and will report
back on Thursday, she said.
Several European countries including Italy have suspended the
Oxford-AstraZeneca jab after reported deaths - at least six in
Italy - after having the vaccine, while stressing this is purely
a precautionary and temporary measure.
Cooke said EMA's assessment of the blood clots will come out on
Thursday and "we assure transparency".
She said "it is our priority to guarantee the safety of the
vaccine and communicate the results".
Cooke stressed that the risk-benefit ratio with the jab "remains
positive, and we are continuing to assess side effects".
She said the current situation "is not unexpected".
The World Health Organization has stressed that the incidence of
clots with the vaccine is lower than that in the general
population, without the vaccine.
ALL RIGHTS RESERVED © Copyright ANSA
